Valuation: Labcorp Holdings Inc.

Capitalization 2.31TCr 1.99TCr 1.81TCr 1.73TCr 3.16TCr 2,12300Cr 3.3TCr 21TCr 8.51TCr 1,01800Cr 8.69TCr 8.5TCr 3,64600Cr P/E ratio 2026 *
20.9x
P/E ratio 2027 * 18.5x
Enterprise value 2.73TCr 2.35TCr 2.13TCr 2.05TCr 3.73TCr 2,50600Cr 3.9TCr 25TCr 10TCr 1,20200Cr 10TCr 10TCr 4,30400Cr EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.74x
Free-Float
99.96%
Yield 2026 *
1.04%
Yield 2027 * 1.05%
1 day-1.76%
1 week-4.07%
Current month-4.57%
1 month-0.83%
3 months+6.78%
6 months-0.99%
Current year+9.98%
1 week 274.24
Extreme 274.24
290.65
1 month 260.57
Extreme 260.57
292.02
Current year 245
Extreme 245
292.02
1 year 209.38
Extreme 209.375
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Change 5d. change 1-year change 3-years change Capi.($)
-1.76%-4.07%+8.51%+16.37% 2.31TCr
-1.83%+1.63%+67.22%+112.32% 12TCr
-2.33%+0.87%+19.32%-5.16% 10TCr
-3.69%-9.20%+17.74%+86.27% 3.16TCr
-2.14%-3.37%+18.59%+45.36% 2.29TCr
-0.25%+0.85%-13.16%-1.25% 2.22TCr
-1.39%+0.72%+91.56%+303.54% 2.13TCr
-3.03%-8.23%+41.33%+61.57% 1.66TCr
+1.40%+3.82%-7.78%+8.17% 1.25TCr
-2.64%-3.61%+10.83%+56.39% 1.24TCr
Average -1.77%-1.45%+25.41%+68.36% 3.87TCr
Weighted average by Cap. -1.99%+0.78%+35.48%+66.02%

Financials

2026 *2027 *
Net sales 1.47TCr 1.26TCr 1.15TCr 1.1TCr 2.01TCr 1,34600Cr 2.09TCr 14TCr 5.4TCr 65TCr 5.51TCr 5.39TCr 2,31200Cr 1.54TCr 1.32TCr 1.2TCr 1.15TCr 2.1TCr 1,41000Cr 2.19TCr 14TCr 5.66TCr 68TCr 5.77TCr 5.64TCr 2,42200Cr
Net income 98Cr 84Cr 76Cr 73Cr 133.43Cr 8.95TCr 139.24Cr 899.93Cr 358.99Cr 4.29TCr 366.23Cr 358.34Cr 15TCr 118.71Cr 102.3Cr 93Cr 89Cr 162.32Cr 11TCr 169.4Cr 1.09TCr 436.73Cr 5.22TCr 445.54Cr 435.93Cr 19TCr
Net Debt 417.25Cr 359.58Cr 325.83Cr 312.55Cr 570.55Cr 38TCr 595.41Cr 3.85TCr 1.54TCr 18TCr 1.57TCr 1.53TCr 66TCr 354.13Cr 305.19Cr 276.54Cr 265.26Cr 484.23Cr 32TCr 505.33Cr 3.27TCr 1.3TCr 16TCr 1.33TCr 1.3TCr 56TCr
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.
Employees
66,385
Date Price Change Volume
04/26/04 280.85 $ -0.76% 4,06,366
03/26/03 282.99 $ -1.21% 3,85,684
02/26/02 286.47 $ -0.92% 4,42,030
27/26/27 289.12 $ +0.52% 6,40,447
26/26/26 287.62 $ +1.71% 6,12,768
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
280.85USD
Average target price
307.59USD
Spread / Average Target
+9.52%

Quarterly revenue - Rate of surprise